Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
Condition:   Follicular Lymphoma Interventions:   Drug: Bendamustine;   Drug: Rituximab;   Drug: Tazemetostat Sponsors:   Vaishalee Kenkre;   Epizyme, Inc.;   University of Wisconsin, Madison Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2022 Category: Research Source Type: clinical trials

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
Condition:   Hodgkin Lymphoma Interventions:   Biological: favezelimab/pembrolizumab;   Drug: bendamustine;   Drug: gemcitabine Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2022 Category: Research Source Type: clinical trials